Prevention of colorectal cancer: The future is now

Isha N. Ranadive, Daniel A Sussman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

An estimated 140,000 new cases of colorectal cancer (CRC) were diagnosed in the USA in 2013. This review focuses on primary, secondary, and tertiary efforts to improve outcomes for patients at risk of CRC. Primary prevention to prevent the occurrence of CRC should focus on the reduction of modifiable CRC risk factors, including education regarding the deleterious effects of Western diets consisting of red and processed meats and the dangers of a sedentary lifestyle and obesity. Foods containing folates, vitamin D, and calcium may be protective against CRC and their consumption should likely be encouraged. Secondary preventive screening efforts can have a profound effect on reducing mortality by identifying neoplasia when precancerous lesions such as adenomas may be removed or when early-stage CRCs exist. Efforts must be made to increase the uptake of CRC screening on a worldwide level. The most resounding data for pharmacologic success in the prophylaxis of colorectal neoplasia belong to the class of aspirin and nonsteroidal anti-inflammatory drugs. Future therapies improving the efficiency of CRC screening modalities and genomic medical breakthroughs to personalize prophylactic treatments will change the way CRC prevention is viewed.

Original languageEnglish
Pages (from-to)84-93
Number of pages10
JournalCurrent Colorectal Cancer Reports
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Colorectal Neoplasms
Early Detection of Cancer
Sedentary Lifestyle
Primary Prevention
Folic Acid
Vitamin D
Adenoma
Aspirin
Neoplasms
Anti-Inflammatory Agents
Obesity
Calcium
Education
Food
Mortality
Therapeutics
Pharmaceutical Preparations

Keywords

  • Colon cancer
  • Colorectal cancer
  • Colorectal neoplasia
  • Prevention

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology
  • Hepatology

Cite this

Prevention of colorectal cancer : The future is now. / Ranadive, Isha N.; Sussman, Daniel A.

In: Current Colorectal Cancer Reports, Vol. 10, No. 1, 01.01.2014, p. 84-93.

Research output: Contribution to journalArticle

@article{f69e4f93274f43c4abb1d0127e7ce077,
title = "Prevention of colorectal cancer: The future is now",
abstract = "An estimated 140,000 new cases of colorectal cancer (CRC) were diagnosed in the USA in 2013. This review focuses on primary, secondary, and tertiary efforts to improve outcomes for patients at risk of CRC. Primary prevention to prevent the occurrence of CRC should focus on the reduction of modifiable CRC risk factors, including education regarding the deleterious effects of Western diets consisting of red and processed meats and the dangers of a sedentary lifestyle and obesity. Foods containing folates, vitamin D, and calcium may be protective against CRC and their consumption should likely be encouraged. Secondary preventive screening efforts can have a profound effect on reducing mortality by identifying neoplasia when precancerous lesions such as adenomas may be removed or when early-stage CRCs exist. Efforts must be made to increase the uptake of CRC screening on a worldwide level. The most resounding data for pharmacologic success in the prophylaxis of colorectal neoplasia belong to the class of aspirin and nonsteroidal anti-inflammatory drugs. Future therapies improving the efficiency of CRC screening modalities and genomic medical breakthroughs to personalize prophylactic treatments will change the way CRC prevention is viewed.",
keywords = "Colon cancer, Colorectal cancer, Colorectal neoplasia, Prevention",
author = "Ranadive, {Isha N.} and Sussman, {Daniel A}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s11888-013-0201-6",
language = "English",
volume = "10",
pages = "84--93",
journal = "Current Colorectal Cancer Reports",
issn = "1556-3790",
publisher = "Springer Science + Business Media",
number = "1",

}

TY - JOUR

T1 - Prevention of colorectal cancer

T2 - The future is now

AU - Ranadive, Isha N.

AU - Sussman, Daniel A

PY - 2014/1/1

Y1 - 2014/1/1

N2 - An estimated 140,000 new cases of colorectal cancer (CRC) were diagnosed in the USA in 2013. This review focuses on primary, secondary, and tertiary efforts to improve outcomes for patients at risk of CRC. Primary prevention to prevent the occurrence of CRC should focus on the reduction of modifiable CRC risk factors, including education regarding the deleterious effects of Western diets consisting of red and processed meats and the dangers of a sedentary lifestyle and obesity. Foods containing folates, vitamin D, and calcium may be protective against CRC and their consumption should likely be encouraged. Secondary preventive screening efforts can have a profound effect on reducing mortality by identifying neoplasia when precancerous lesions such as adenomas may be removed or when early-stage CRCs exist. Efforts must be made to increase the uptake of CRC screening on a worldwide level. The most resounding data for pharmacologic success in the prophylaxis of colorectal neoplasia belong to the class of aspirin and nonsteroidal anti-inflammatory drugs. Future therapies improving the efficiency of CRC screening modalities and genomic medical breakthroughs to personalize prophylactic treatments will change the way CRC prevention is viewed.

AB - An estimated 140,000 new cases of colorectal cancer (CRC) were diagnosed in the USA in 2013. This review focuses on primary, secondary, and tertiary efforts to improve outcomes for patients at risk of CRC. Primary prevention to prevent the occurrence of CRC should focus on the reduction of modifiable CRC risk factors, including education regarding the deleterious effects of Western diets consisting of red and processed meats and the dangers of a sedentary lifestyle and obesity. Foods containing folates, vitamin D, and calcium may be protective against CRC and their consumption should likely be encouraged. Secondary preventive screening efforts can have a profound effect on reducing mortality by identifying neoplasia when precancerous lesions such as adenomas may be removed or when early-stage CRCs exist. Efforts must be made to increase the uptake of CRC screening on a worldwide level. The most resounding data for pharmacologic success in the prophylaxis of colorectal neoplasia belong to the class of aspirin and nonsteroidal anti-inflammatory drugs. Future therapies improving the efficiency of CRC screening modalities and genomic medical breakthroughs to personalize prophylactic treatments will change the way CRC prevention is viewed.

KW - Colon cancer

KW - Colorectal cancer

KW - Colorectal neoplasia

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=84896546380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896546380&partnerID=8YFLogxK

U2 - 10.1007/s11888-013-0201-6

DO - 10.1007/s11888-013-0201-6

M3 - Article

AN - SCOPUS:84896546380

VL - 10

SP - 84

EP - 93

JO - Current Colorectal Cancer Reports

JF - Current Colorectal Cancer Reports

SN - 1556-3790

IS - 1

ER -